Merus N.V.
MRUSDelisted Dec 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651311
Merus N.V. was delisted on Dec 30, 2025; its insiders filed their last Form 4 on Dec 30, 2025; 268 institutions reported holding it in 13F filings for Q3 2025, worth $6.70B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Merus N.V. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 185
- −6 vs. Q4 2024
- Shares held
- 70.8M
- +499.9K (+0.7%) vs. Q4 2024
- Total value
- $2.98B
- +$25.0M (+0.8%) vs. Q4 2024
- New holders
- 24
- 72 more added
- Sold out
- 30
- 63 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 10 | $5.73M |
| Q3 2025 | 268 | $6.70B |
| Q2 2025 | 201 | $3.93B |
| Q1 2025 | 185 | $2.98B |
| Q4 2024 | 192 | $2.96B |
| Q3 2024 | 189 | $3.45B |
| Q2 2024 | 179 | $3.94B |
| Q1 2024 | 156 | $2.31B |
| Q4 2023 | 131 | $1.41B |
| Q3 2023 | 113 | $1.12B |
| Q2 2023 | 114 | $1.09B |
| Q1 2023 | 104 | $672.0M |
| Q4 2022 | 91 | $563.8M |
| Q3 2022 | 100 | $687.4M |
| Q2 2022 | 93 | $793.4M |
| Q1 2022 | 95 | $878.1M |
| Q4 2021 | 103 | $1.05B |
| Q3 2021 | 64 | $487.8M |
| Q2 2021 | 68 | $564.3M |
| Q1 2021 | 59 | $558.3M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Merus N.V.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caption Management, LLC | 0 | $0 | 0.00% | −8,343−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −8,020−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −5,075−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −2,888−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −2,007−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −1,815−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −1,716−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −752−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |